573 related articles for article (PubMed ID: 7521686)
1. Mice lacking granulocyte colony-stimulating factor have chronic neutropenia, granulocyte and macrophage progenitor cell deficiency, and impaired neutrophil mobilization.
Lieschke GJ; Grail D; Hodgson G; Metcalf D; Stanley E; Cheers C; Fowler KJ; Basu S; Zhan YF; Dunn AR
Blood; 1994 Sep; 84(6):1737-46. PubMed ID: 7521686
[TBL] [Abstract][Full Text] [Related]
2. Essential roles for granulocyte-macrophage colony-stimulating factor (GM-CSF) and G-CSF in the sustained hematopoietic response of Listeria monocytogenes-infected mice.
Zhan Y; Lieschke GJ; Grail D; Dunn AR; Cheers C
Blood; 1998 Feb; 91(3):863-9. PubMed ID: 9446646
[TBL] [Abstract][Full Text] [Related]
3. Mice lacking both granulocyte colony-stimulating factor (CSF) and granulocyte-macrophage CSF have impaired reproductive capacity, perturbed neonatal granulopoiesis, lung disease, amyloidosis, and reduced long-term survival.
Seymour JF; Lieschke GJ; Grail D; Quilici C; Hodgson G; Dunn AR
Blood; 1997 Oct; 90(8):3037-49. PubMed ID: 9376584
[TBL] [Abstract][Full Text] [Related]
4. Increased granulocyte colony-stimulating factor responsiveness but normal resting granulopoiesis in mice carrying a targeted granulocyte colony-stimulating factor receptor mutation derived from a patient with severe congenital neutropenia.
McLemore ML; Poursine-Laurent J; Link DC
J Clin Invest; 1998 Aug; 102(3):483-92. PubMed ID: 9691084
[TBL] [Abstract][Full Text] [Related]
5. Lineage-specific growth factors can compensate for stem and progenitor cell deficiencies at the postprogenitor cell level: an analysis of doubly TPO- and G-CSF receptor-deficient mice.
Kaushansky K; Fox N; Lin NL; Liles WC
Blood; 2002 May; 99(10):3573-8. PubMed ID: 11986210
[TBL] [Abstract][Full Text] [Related]
6. Contrasting effects of recombinant human granulocyte-macrophage colony-stimulating factor (CSF) and granulocyte CSF treatment on the cycling of blood elements in childhood-onset cyclic neutropenia.
Wright DG; Kenney RF; Oette DH; LaRussa VF; Boxer LA; Malech HL
Blood; 1994 Aug; 84(4):1257-67. PubMed ID: 7519479
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo effects of granulocyte colony-stimulating factor on neutrophils in glycogen storage disease type 1B: granulocyte colony-stimulating factor therapy corrects the neutropenia and the defects in respiratory burst activity and Ca2+ mobilization.
McCawley LJ; Korchak HM; Douglas SD; Campbell DE; Thornton PS; Stanley CA; Baker L; Kilpatrick L
Pediatr Res; 1994 Jan; 35(1):84-90. PubMed ID: 7510873
[TBL] [Abstract][Full Text] [Related]
8. Genetic influences determining progenitor cell mobilization and leukocytosis induced by granulocyte colony-stimulating factor.
Roberts AW; Foote S; Alexander WS; Scott C; Robb L; Metcalf D
Blood; 1997 Apr; 89(8):2736-44. PubMed ID: 9108391
[TBL] [Abstract][Full Text] [Related]
9. Essential role for cyclin D3 in granulocyte colony-stimulating factor-driven expansion of neutrophil granulocytes.
Sicinska E; Lee YM; Gits J; Shigematsu H; Yu Q; Rebel VI; Geng Y; Marshall CJ; Akashi K; Dorfman DM; Touw IP; Sicinski P
Mol Cell Biol; 2006 Nov; 26(21):8052-60. PubMed ID: 16954383
[TBL] [Abstract][Full Text] [Related]
10. Myeloid development is selectively disrupted in PU.1 null mice.
Anderson KL; Smith KA; Conners K; McKercher SR; Maki RA; Torbett BE
Blood; 1998 May; 91(10):3702-10. PubMed ID: 9573007
[TBL] [Abstract][Full Text] [Related]
11. Induction of granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF) expression in bone marrow and fractionated marrow cell populations by interleukin 3 (IL-3): IL-3-mediated positive feedback mechanisms of granulopoiesis.
Tsuji T; Sugimoto K; Yanai T; Takashita E; Mori KJ
Growth Factors; 1994; 11(1):71-9. PubMed ID: 7530467
[TBL] [Abstract][Full Text] [Related]
12. "Emergency" granulopoiesis in G-CSF-deficient mice in response to Candida albicans infection.
Basu S; Hodgson G; Zhang HH; Katz M; Quilici C; Dunn AR
Blood; 2000 Jun; 95(12):3725-33. PubMed ID: 10845903
[TBL] [Abstract][Full Text] [Related]
13. Comparative effects of granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF) on priming peripheral blood progenitor cells for use with autologous bone marrow after high-dose chemotherapy.
Peters WP; Rosner G; Ross M; Vredenburgh J; Meisenberg B; Gilbert C; Kurtzberg J
Blood; 1993 Apr; 81(7):1709-19. PubMed ID: 7681699
[TBL] [Abstract][Full Text] [Related]
14. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
[TBL] [Abstract][Full Text] [Related]
15. GRK6 deficiency is associated with enhanced CXCR4-mediated neutrophil chemotaxis in vitro and impaired responsiveness to G-CSF in vivo.
Vroon A; Heijnen CJ; Raatgever R; Touw IP; Ploemacher RE; Premont RT; Kavelaars A
J Leukoc Biol; 2004 Apr; 75(4):698-704. PubMed ID: 14704365
[TBL] [Abstract][Full Text] [Related]
16. Increased granulopoiesis through interleukin-17 and granulocyte colony-stimulating factor in leukocyte adhesion molecule-deficient mice.
Forlow SB; Schurr JR; Kolls JK; Bagby GJ; Schwarzenberger PO; Ley K
Blood; 2001 Dec; 98(12):3309-14. PubMed ID: 11719368
[TBL] [Abstract][Full Text] [Related]
17. Long-term marrow reconstitutive ability of autologous grafts in lymphoma patients using peripheral blood mobilized with granulocyte colony-stimulating factor or granulocyte-macrophage colony-stimulating factor compared to bone marrow.
Benboubker L; Cartron G; Roingeard F; Delain M; Degenne M; Linassier C; Hérault O; Truglio D; Bout M; Petit A; Brémond JL; Desbois I; Colombat P; Binet C; Domenech J
Exp Hematol; 2003 Jan; 31(1):89-97. PubMed ID: 12543111
[TBL] [Abstract][Full Text] [Related]
18. Stem cell factor in combination with granulocyte colony-stimulating factor (CSF) or granulocyte-macrophage CSF synergistically increases granulopoiesis in vivo.
Ulich TR; del Castillo J; McNiece IK; Yi ES; Alzona CP; Yin SM; Zsebo KM
Blood; 1991 Oct; 78(8):1954-62. PubMed ID: 1717076
[TBL] [Abstract][Full Text] [Related]
19. Effect of recombinant human granulocyte colony-stimulating factor administration in normal and experimentally infected newborn rats.
Iguchi K; Inoue S; Kumar A
Exp Hematol; 1991 Jun; 19(5):352-8. PubMed ID: 1709109
[TBL] [Abstract][Full Text] [Related]
20. Myeloid cell kinetics in mice treated with recombinant interleukin-3, granulocyte colony-stimulating factor (CSF), or granulocyte-macrophage CSF in vivo.
Lord BI; Molineux G; Pojda Z; Souza LM; Mermod JJ; Dexter TM
Blood; 1991 May; 77(10):2154-9. PubMed ID: 1709372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
